TP53 MUTATIONS IN CODON 273 IS PREDICTIVE OF OVERALL SURVIVAL IN ASTROCYTOMA PATIENTS

被引：0
|
作者：
Noor, H. [1 ]
Rapkins, R. [1 ]
McDonald, K. [1 ]
机构：
[1] Univ New South Wales, Sydney, NSW, Australia
来源：
NEURO-ONCOLOGY | 2019年 / 21卷
关键词：
D O I：
10.1093/neuonc/noz126.111
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P04.16
引用
收藏
页码：32 / 32
页数：1
相关论文
共 50 条
  • [31] TP53 codon 72 polymorphism may predict early tumour progression in paediatric pilocytic astrocytoma
    Mascelli, Samantha
    Nozza, Paolo
    Jones, David T. W.
    Colin, Carole
    Pistorio, Angela
    Milanaccio, Claudia
    Ravegnani, Marcello
    Consales, Alessandro
    Witt, Olaf
    Morana, Giovanni
    Cama, Armando
    Capra, Valeria
    Biassoni, Roberto
    Pfister, Stefan M.
    Figarella-Branger, Dominique
    Garre, Maria Luisa
    Raso, Alessandro
    ONCOTARGET, 2016, 7 (30) : 47918 - 47926
  • [32] TP53 codon 72 polymorphism in patients with chronic myeloid leukemia
    Bergamaschi, G
    Merante, S
    Orlandi, E
    Galli, A
    Bernasconi, P
    Cazzola, M
    HAEMATOLOGICA, 2004, 89 (07) : 868 - 869
  • [33] Analysis of the codon 72 polymorphism of the TP53 gene in patients with endometriosis
    Lattuada, D
    Viganò, P
    Somigliana, E
    Abbiati, A
    Candiani, M
    Di Blasio, AM
    MOLECULAR HUMAN REPRODUCTION, 2004, 10 (09) : 651 - 654
  • [34] TP53 mutations at codon 234 are associated with chlorambucil treatment in chronic lymphocytic leukemia
    Lazarian, Gregory
    Theves, Floriane
    Hormi, Myriam
    Letestu, Remi
    Eclache, Virginie
    Bidet, Audrey
    Cornillet-Lefebvre, Pascale
    Davi, Frederic
    Delabesse, Eric
    Estienne, Marie-Helene
    Etancelin, Pascaline
    Kosmider, Olivier
    Laibe, Sophy
    Lode, Laurence
    Muller, Marc
    Nadal, Nathalie
    Naguib, Dina
    Pastoret, Cedric
    Poulain, Stephanie
    Sujobert, Pierre
    Veronese, Lauren
    Imache, Samia
    Lefebvre, Valerie
    Cymbalista, Florence
    Baran-Marszak, Fanny
    Soussi, Thierry
    AMERICAN JOURNAL OF HEMATOLOGY, 2022, 97 (04) : E159 - E162
  • [35] TP53 mutations in myelodysplastic syndrome
    Misawa, S
    Horiike, S
    LEUKEMIA & LYMPHOMA, 1996, 23 (5-6) : 417 - 422
  • [36] Nondisruptive mutations of TP53 and overall survival (OS) in advanced non-small-cell lung cancer (NSCLC) patients (p)
    Costa, Enric Carcereny
    Bertran-Alamillo, Jordi
    Molina-Vila, Miguel Angel
    Gervais, Radj
    Massuti, Bartomeu
    Bonanno, Laura
    Moran, Teresa
    Majem, Margarita
    Felip, Enriqueta
    Garcia-Campelo, M. Rosario
    Vergnenegre, Alain
    Ramirez, Santiago Viteri
    Gasco, Amaya
    Wannesson, Luciano
    Mayo-de las Casas, Clara
    Pujantell-Pastor, Laia
    Favaretto, Adolfo G.
    Karachaliou, Niki
    Rosell, Rafael
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [37] Landscape of TP53 Mutations in MPN
    Farnoud, Noushin
    Famulare, Christopher
    Papaemmanuil, Elli
    McGovern, Erin
    Medina, Juan
    Ossa, Juan E. Arango
    Rampal, Raajit K.
    Li, Bing
    Levine, Ross L.
    Mascarenhas, John
    Weinberg, Rona Singer
    Patel, Minal A.
    Hoffman, Ronald
    BLOOD, 2019, 134
  • [38] Germline mutations in the TP53 gene
    Eeles, RA
    CANCER SURVEYS, 1995, 25 : 101 - 124
  • [39] TP53 mutations in human meningiomas
    Verheijen, FM
    Sprong, M
    Kloosterman, JME
    Blaauw, G
    Thijssen, JHH
    Blankenstein, MA
    INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS, 2002, 17 (01): : 42 - 48
  • [40] Are TP53 mutations all alike?
    Wong, Terrence N.
    Link, Daniel C.
    HEMATOLOGY-AMERICAN SOCIETY OF HEMATOLOGY EDUCATION PROGRAM, 2024, (01) : 321 - 325
12345